| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Revenue | $1.7B | $1.8B | $1.7B | $1.8B | $1.6B |
| Cost of Revenue | $3.9B | $4.0B | $4.2B | $4.4B | $4.0B |
| Gross Profit | $0.5B | $0.6B | $0.6B | $0.6B | $0.5B |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | $1.5B | $1.4B | $1.4B | $1.4B | $1.3B |
| Operating Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| Net Income | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $1.93 | $2.27 | $2.03 | $1.61 | $1.01 |
| EPS (Diluted) | $1.89 | $2.21 | $1.97 | $1.57 | $0.97 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Total Assets | $4.9B | $4.7B | $4.6B | $4.6B | $4.4B |
| Current Assets | $1.7B | $1.6B | $1.7B | $1.7B | $1.4B |
| Cash & Equivalents | $0.3B | $0.3B | $0.3B | $0.5B | $0.4B |
| Total Liabilities | $2.9B | $2.7B | $3.0B | $3.1B | $3.3B |
| Current Liabilities | $1.0B | $0.9B | $1.0B | $1.1B | $1.2B |
| Stockholders' Equity | $2.0B | $2.0B | $1.6B | $1.5B | $1.1B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.6B | $0.7B | $1.0B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.1B | $-0.1B | $-0.0B |
| Capital Expenditures | $0.2B | $0.2B | $0.1B | $0.1B | — |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.6B | $-0.5B | $-0.8B |